Chemed director Patrick Grace sells $101,080 in company stock By Investing.com

Patrick P. Grace, a director at CHEMED CORP (), recently sold shares of the company’s capital stock. The transaction, which took place on July 31, 2026, involved the sale of 190 shares. The shares were sold at a price of $532.0 per share, totaling $101,080. The sale came as CHEMED stock trades near its 52-week high of $551.68, with shares up 25% year-to-date.

Following this transaction, Mr. Grace directly holds 3,533 shares of CHEMED CORP capital stock. According to InvestingPro analysis, the stock appears undervalued at current levels. The company has raised its dividend for 17 consecutive years, one of several key insights available in the comprehensive Pro Research Report covering CHE and 1,400+ other US equities.

In other recent news, Chemed Corporation announced its second-quarter earnings, surpassing Wall Street expectations. The company reported adjusted earnings of $6.06 per share on revenue of $673.25 million. These results exceeded analysts’ projections, which had anticipated earnings of $5.60 per share and revenue of $665.04 million. The impressive performance was driven by strong growth in Chemed’s hospice unit, VITAS, along with consistent results from Roto-Rooter. The adjusted earnings per share increased by 41.9% compared to the previous year, indicating improved operating leverage. These developments have positioned Chemed favorably in the eyes of analysts and investors alike.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.